Vaccines
Sanofi-aventis Announces Second Quarter 2009 Results
Published in Health Business Week, August 14th, 2009
Taxotere (up 10.7%). Further dynamism in the worldwide presence of
Plavix (up 9.6%) -- Growth of 18.4% for the Vaccines business excluding H5N1 contracts(2) -- Net sales growth of 5.4% in the U.S., 4.6% in Europe and 20.1% in
Emerging Markets -- Multaq : approved by the FDA on July 1, and launched in the United
States on July 28 2009 Results and Guidance -- 2009 second-quarter growth of adjusted EPS excluding selected items of
17.2% at constant exchange rates and 29.9% on a reported basis -- Strong cash flow from operating...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-08-14)
More Articles from Health Business Week
- 1-800-FLOWERS.COM, Inc.
Celebrate National Friendship Day With 1-800-FLOWERS.COM - 3M
3M Introduces Highly Conformable, Non-Woven Conductive Tapes - AARP
Consumer Cellular Offers AARP Members Additional Value - Abbott
Abbott and Medtronic Reach Agreement on Global Patent Disputes - Abbott
Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education - Acceleron Pharma, Inc.
Acceleron and Celgene Initiate Phase 2 Study of ACE-011 to Treat Chemotherapy-Induced Anemia - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
